Condition
CRBSI - Catheter Related Bloodstream Infection
Total Trials
6
Recruiting
1
Active
2
Completed
3
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 6 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 3 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
4Total
Not Applicable (3)
P 2 (1)
Trial Status
Completed3
Unknown1
Recruiting1
Active Not Recruiting1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 3 completed trials
Clinical Trials (6)
Showing 6 of 6 trials
NCT06604026Not ApplicableCompletedPrimary
Investigational Study With the BD PosiFlush™ SafeScrub on NADs
NCT06085690Not ApplicableRecruitingPrimary
Multicenter Clinical Translational Study of "ICU-NO CRBSI" Based on Improvement Science
NCT07138690CompletedPrimary
Complications and Failure of Centrally Inserted Central Catheters in Cardiac Surgical Patients
NCT06566495Active Not Recruiting
Microorganisms on Reusable Tourniquets
NCT05813535Phase 2Unknown
8.4% Sodium Bicarbonate Locks in Intestinal Failure
NCT04927325Not ApplicableCompleted
Erythema at Exit Site & Tablet Camera
Showing all 6 trials